Current Value of Holding

$2.68 Million

Shares

208 Thousand

% of Portfolio

0.03%

Average Buy Price

$51.5

Avg closing price
Price range

43 Paul Tudor Jones II Integra Lifesciences Holdings Trades

Paul Tudor Jones II's position in Integra Lifesciences Holdings is currently worth $2.68 Million. That's 0.03% of their equity portfolio (575th largest holding). The first Integra Lifesciences Holdings trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 25 more times and sold shares on seventeen occasions. The investor's estimated purchase price is $10.7 Million, resulting in a loss of 75%.

Avg closing price
Price range
Sold 23.3% shares (-63.3 Thousand shares) Q4 2024
Avg closing price $21.88
Price range $16.95 - $26.70
Sold 3.5% shares (-9.9 Thousand shares) Q3 2024
Avg closing price $23.22
Price range $17.14 - $31.74
Increased shares by 3.1% (+8.54 Thousand shares) Q2 2024
Avg closing price $29.66
Price range $23.14 - $34.72
Increased shares by 84.0% (+125 Thousand shares) Q1 2024
Avg closing price $40.00
Price range $33.40 - $45.20
Increased shares by 46.2% (+46.9 Thousand shares) Q4 2023
Avg closing price $39.35
Price range $34.21 - $44.59
Sold 50.6% shares (-104 Thousand shares) Q3 2023
Avg closing price $42.07
Price range $37.80 - $45.97
Increased shares by 4.2% (+8.29 Thousand shares) Q2 2023
Avg closing price $48.13
Price range $37.95 - $58.98
Increased shares by 3.1% (+5.95 Thousand shares) Q1 2023
Avg closing price $56.35
Price range $52.61 - $60.49
Increased shares by 31.6% (+45.9 Thousand shares) Q4 2022
Avg closing price $50.90
Price range $41.79 - $58.60
Increased shares by 26.6% (+30.5 Thousand shares) Q3 2022
Avg closing price $51.24
Price range $42.28 - $57.17
Increased shares by 50.3% (+38.4 Thousand shares) Q2 2022
Avg closing price $60.06
Price range $53.86 - $66.52
Increased shares by 437.1% (+62.1 Thousand shares) Q1 2022
Avg closing price $65.84
Price range $62.86 - $69.24
Increased shares by 38.2% (+3.93 Thousand shares) Q4 2021
Avg closing price $67.65
Price range $62.47 - $73.25
Sold 79.4% shares (-39.6 Thousand shares) Q3 2021
Avg closing price $70.65
Price range $64.97 - $76.19
New holding (+49.8 Thousand shares) Q2 2021
Avg closing price $70.72
Price range $66.79 - $76.63
Sold -21.7 Thousand shares Q1 2021
Avg closing price $67.75
Price range $62.63 - $71.15
New holding (+21.7 Thousand shares) Q4 2020
Avg closing price $53.81
Price range $43.31 - $66.55
Sold -22.5 Thousand shares Q3 2020
Avg closing price $47.57
Price range $43.33 - $51.72
Increased shares by 68.9% (+9.18 Thousand shares) Q2 2020
Avg closing price $49.15
Price range $41.42 - $55.57
Increased shares by 146.5% (+7.92 Thousand shares) Q1 2020
Avg closing price $52.48
Price range $36.67 - $61.04

News about Integra Lifesciences Holdings Corp and Paul Tudor Jones II

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!